ArticleJournal of experimental & clinical cancer research : CR2020

Correction to: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma.

Fei Teng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.